Study 1TNFA expression (inflammation)COL1A1 expression (fibrosis)CD31 expression (vascularity)Study 2Major adverse cardiovascular events (composite endpoint of cardiac mortality and non-fatal myocardial infarction)Study 3Acute myocardial infarction vs. stable CAD. This evidence concerns the gene COL1A1 and coronary artery disorder.